Plain-English translation of NCT05947656 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the NaviFUS System, a noninvasive focused ultrasound device that delivers gentle sound waves directly to the part of your brain causing seizures. The treatment aims to calm abnormal brain signals and reduce how often you have seizures. Unlike surgery, this approach doesn't require cutting into the brain.
About 30% of people with epilepsy continue to have seizures even after trying multiple medications. Surgery can help, but many patients are not good candidates for it. This trial explores whether the new treatment could offer a safe middle-ground option for people who desperately need better seizure control.
You likely qualify if…
You likely don't qualify if…
You will come in for focused ultrasound treatments twice a week for either two or three weeks (depending on which group you join), with each treatment session lasting less than an hour. After your treatment sessions end, you'll have three follow-up visits over the next few months to check for safety and measure whether your seizures have decreased. Throughout the trial, you'll keep a seizure diary and take the same epilepsy medications you're currently on.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Australia